Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

Healthcare Cannabis
THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

THC Biomed Intl Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(36)
•••
Post by ART535455on Mar 11, 2021 11:10am
100 Views
Post# 32772461

NEW PRICE TARGET $.51 PLUS 2 POSITIVE QUARTERS FOE 2021

NEW PRICE TARGET $.51 PLUS 2 POSITIVE QUARTERS FOE 2021

 THC Biomed INTL Earnings Date & Forecast

Report Date
Mar 26, 2021
To be announced
Period Ending
2021 (Q2)
Consensus EPS Forecast
—
Last Year’s EPS
C$0.00099
Same Quarter Last Year
Analyst Consensus
Moderate Buy
Based on 1 Analyst Ratings
C$0.51(195.62% Upside)

THC Biomed INTL (TSE:THC) Revenues Date & History

Revenue vs EarningsRevenueEarningsQ1 2019Q4 2019Q1 2020Q2 2020Q3 2020-C$7.2M-C$4.8M-C$2.4MC$0C$2.4MC$4.8M

Revenue is the income a company generates from its business activities. Earnings refer to the company’s income after tax and expenses are deducted.

Daily Earnings Calendar >
Daily Dividend Calendar >

 
 
 
 
 
 
 
 
 
 

The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets.

See Top Smart Score Stocks >
About Smart Score & Performance >
 

TSE:THC Earnings History

 

The table below compares between the EPS and the revenue to the given forecast showing the beat and missed predictions.
 
Beat
 
Missed

 

 
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Mar 26, 2021
2021 (Q2)
-----
/
-----
0.001
-----
Dec 24, 2020
2021 (Q1)
-----
/
-----
0.004
-----
Nov 13, 2020
2020 (Q4)
-----
/
-0.004
0.004
-200.00% (-0.008)
Jun 26, 2020
2020 (Q3)
-----
/
-0.002
-0.035
94.29% (+0.033)
Apr 8, 2020
2020 (Q2)
-----
/
0.001
-0.039
102.56% (+0.04)
Nov 26, 2019
2020 (Q1)
-----
/
0.004
0.009
-55.56% (-0.005)
Mar 29, 2019
2019 (Q2)
-----
/
-0.039
-0.08
51.25% (+0.041)
Loading...
 
 

 THC Biomed INTL Earnings Date & Forecast

Report Date
Mar 26, 2021
To be announced
Period Ending
2021 (Q2)
Consensus EPS Forecast
—
Last Year’s EPS
C$0.00099
Same Quarter Last Year
Analyst Consensus
Moderate Buy
Based on 1 Analyst Ratings
C$0.51(195.62% Upside)

THC Biomed INTL (TSE:THC) Revenues Date & History

Revenue vs EarningsRevenueEarningsQ1 2019Q4 2019Q1 2020Q2 2020Q3 2020-C$7.2M-C$4.8M-C$2.4MC$0C$2.4MC$4.8M

Revenue is the income a company generates from its business activities. Earnings refer to the company’s income after tax and expenses are deducted.

Daily Earnings Calendar >
Daily Dividend Calendar >

 
 
 
 
 
 
 
 
 
 

The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets.

See Top Smart Score Stocks >
About Smart Score & Performance >
 

TSE:THC Earnings History

 

The table below compares between the EPS and the revenue to the given forecast showing the beat and missed predictions.
 
Beat
 
Missed

 

 
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Mar 26, 2021
2021 (Q2)
-----
/
-----
0.001
-----
Dec 24, 2020
2021 (Q1)
-----
/
-----
0.004
-----
Nov 13, 2020
2020 (Q4)
-----
/
-0.004
0.004
-200.00% (-0.008)
Jun 26, 2020
2020 (Q3)
-----
/
-0.002
-0.035
94.29% (+0.033)
Apr 8, 2020
2020 (Q2)
-----
/
0.001
-0.039
102.56% (+0.04)
Nov 26, 2019
2020 (Q1)
-----
/
0.004
0.009
-55.56% (-0.005)
Mar 29, 2019
2019 (Q2)
-----
/
-0.039
-0.08
51.25% (+0.041)
Loading...
 
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities